PARP Inhibitor Combination Shows Activity in Small Cell Lung Cancer - Cancer Therapy Advisor
PARP Inhibitor Combination Shows Activity in Small Cell Lung Cancer Cancer Therapy Advisor
Olaparib plus temozolomide appeared safe and active in relapsed small cell lung cancer, according to the results of a single-arm phase 1/2 trial.
Comments
Post a Comment